| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |